2 photos positioned along a road. First photo is Elliot in a baseball uniform. Second photo is Elliot's parents and siblings aboard a cruise ship.
Participant Spotlight
Read more
Making the time for T1D research — The Ebner Family, Monroe, Connecticut
With four boys who are active in multiple sports, the Ebners are a busy family. But when one of the Ebner sons was diagnosed with type 1 diabetes (T1D), the family made the time for T1D research.
Headshots of researchers involved in the BANDIT trial in new onset diabetes
Research Spotlight
Read more
Groundbreaking study finds JAK inhibitor baricitinib slows type 1 diabetes progression
World-first study findings by Australian researchers show a daily pill containing the JAK inhibitor baricitinib can preserve insulin production in people newly diagnosed with T1D. Published in the December issue of the New England Journal of Medicine, findings were co-authored by Thomas Kay, MBBS, PhD, and Helen Thomas, PhD, St.
Blue background featuring a collage of photos from research participants. Text in the image reads "a message to our TrialNet family" and "celebrating 2023"
Media Release
Read more
Celebrating a New Era in Type 1 Diabetes Research - A Message from TrialNet Chair Kevan C. Herold, MD
TrialNet Chair Kevan C. Herold, MD, Yale University, reflects on key accomplishments of the past year and shares direction for 2024 and beyond.
Dear TrialNet family,
As we start the new year, I want to take time to recognize TrialNet’s major achievements in 2023 and share our direction for advancing type 1 diabetes (T1D) research in the year ahead.
